BURLINGTON, Mass., Nov. 8, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in two upcoming Investor Conferences. The first is the Three Part Advisors Southwest IDEAS Investor Conference at the Sheraton Dallas Hotel in Dallas, TX, on Wednesday, November 20, 2013. The second is the Brean Capital 2013 Life Sciences Summit at Convene in New York, NY, on Monday, November 25, 2013. Management will provide an update on the Company at both conferences.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at http://www.lemaitre.com.
LeMaitre and the LeMaitre Vascular logo are registered trademarks of LeMaitre Vascular, Inc.
CONTACT: LeMaitre Vascular, Inc.Mary Nielson
LeMaitre Vascular, Inc.